PCT/2002/19 - World Intellectual Property Organization
PCT/2002/19 - World Intellectual Property Organization
PCT/2002/19 - World Intellectual Property Organization
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>19</strong>/<strong>2002</strong><br />
9030 <strong>PCT</strong> Gazette - Section I - Gazette du <strong>PCT</strong> 10 May/mai <strong>2002</strong><br />
LK LR LS LT LU LV MA MD MG MK MN<br />
MW MX MZ NO NZ PH PL PT RO RU SD<br />
SE SG SI SK SL TJ TM TR TT TZ UA UG<br />
US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GQ GW ML<br />
MR NE SN TD TG).<br />
(51) 7 A61K 38/18, A61P 37/00<br />
(11) WO 02/36151 (13) A2<br />
(21) <strong>PCT</strong>/IT01/00530<br />
(22) 18 Oct/oct 2001 (18.10.2001)<br />
(25) en (26) en<br />
(30) RM2000A000571 3 Nov/nov 2000 IT<br />
(03.11.2000)<br />
(43) 10 May/mai <strong>2002</strong> (10.05.<strong>2002</strong>)<br />
(54) USE OF THE LONG PENTRAXIN PTX3<br />
FOR THE PREPARATION OF MEDICA-<br />
MENT FOR THE PREVENTION AND<br />
CURE OF AUTOIMMUNE PATHOLO-<br />
GIES<br />
UTILISATION DE LA PENTRAXINE<br />
PTX3 LONGUE POUR LA PREPA-<br />
RATION D’UN MEDICAMENT UTI-<br />
LISE POUR LA PREVENTION ET LE<br />
TRAITEMENT DE PATHOLOGIES<br />
AUTO-IMMUNES<br />
(71) SIGMA-TAU INDUSTRIE FARMACEU-<br />
TICHE RIUNITE S.P.A. [IT/IT]; Viale<br />
Shakespeare, 47, I-00144 Rome (IT).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) MANTOVANI, Alberto [IT/IT]; c/o<br />
Istituto di Ricerche Farmacologiche "Mario<br />
Negri", Via Eritrea, 62, I-20157 Milan (IT).<br />
BOTTAZI, Barbara [IT/IT]; c/o Istituto<br />
di Ricerche Farmacologiche "Mario Negri",<br />
Via Eritrea, 62, I-20157 Milan (IT). PERI,<br />
Giuseppe [IT/IT]; c/o Istituto di Ricerche<br />
Farmacologiche "Mario Negri", Via Eritrea,<br />
62, I-20157 Milan (IT). MANFREDI,<br />
Angelo [IT/IT]; c/o Istituto di Ricerche Farmacologiche<br />
"Mario Negri", Via Eritrea, 62,<br />
I-20157 Milan (IT).<br />
(74) SPADARO, Marco; Cavattoni - Raimondi,<br />
Viale dei Parioli, 160, I-00<strong>19</strong>7 Roma (IT).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ PH PL PT RO RU<br />
SD SE SG SI SK SL TJ TM TR TT TZ UA<br />
UG US UZ VN YU ZA ZW.<br />
Declarations / Déclarations :<br />
(s) for all designations / pour toutes les<br />
désignations<br />
(t) for the following designation / pour la<br />
désignation suivante : US<br />
(u) for / pour US only / seulement<br />
(51) 7 A61K 38/18, A61P 7/06, A61K 38/20,<br />
47/48, 39/395 // (A61K 38/20, 38:18) (A61K<br />
38/18, 38:17) (A61K 39/395, 38:18)<br />
(11) WO 02/36152 (13) A1<br />
(21) <strong>PCT</strong>/US01/46205<br />
(22) 30 Oct/oct 2001 (30.10.2001)<br />
(25) en (26) en<br />
(30) 60/244,792 31 Oct/oct 2000 US<br />
(31.10.2000)<br />
(30) 09/969,739 2 Oct/oct 2001 US<br />
(02.10.2001)<br />
(43) 10 May/mai <strong>2002</strong> (10.05.<strong>2002</strong>)<br />
(54) USE OF IL-1 INHIBITORS AND<br />
TNF ANTAGONISTS, PARTIALLY<br />
IN COMBINATION WITH RECOMBI-<br />
NANT ERYTHROPOIETINS, FOR THE<br />
TREATMENT OF ANEMIA<br />
UTILISATION D’INHIBITEURS IL-1<br />
ET D’ANTAGONISTES TNF, EN PAR-<br />
TIE EN COMBINAISON AVEC DES<br />
ERYTHROPOIETINES DE RECOMBI-<br />
NAISON, POUR TRAITER L’ANEMIE<br />
(71) AMGEN INC. [US/US]; One Amgen Center<br />
Drive, Thousand Oaks, CA 91320-1799 (US).<br />
(72) KAY, Jonathan; 62 Olde Field Road,<br />
Newton Center, ME 02459-2734 (US). MC-<br />
CABE, Dorothy; 10708 Pimlico, Moorpark,<br />
CA 93021 (US). NEWMARK, Richard;<br />
998 Via Candella, Newbury Park, CA 91320<br />
(US). COCCIA, Marco, A.; 2242 Barbara<br />
Drive, Camarillo, CA 93012 (US).<br />
(74) ODRE, Steven, M. et al. / etc.; Amgen Inc.,<br />
One Amgen Center Drive, M/S 27-4-A, Thousand<br />
Oaks, CA 91320-1799 (US).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ OM PH PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TR TT TZ<br />
UA UG UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GQ GW ML<br />
MR NE SN TD TG).<br />
Published / Publiée :(c)<br />
(51) 7 A61K 38/21, A61P 43/00<br />
(11) WO 02/36153<br />
(21) <strong>PCT</strong>/JP01/08390<br />
(13) A1<br />
(22) 26 Sep/sep 2001 (26.09.2001)<br />
(25) ja (26) ja<br />
(30) 2000-328539 27 Oct/oct 2000<br />
(27.10.2000)<br />
JP<br />
(30) 2001-116710 16 Apr/avr 2001<br />
(16.04.2001)<br />
JP<br />
(43) 10 May/mai <strong>2002</strong> (10.05.<strong>2002</strong>)<br />
(54) EXPRESSION POTENTIATOR FOR<br />
PROTEIN SYNTHESIS REGULATORY<br />
GENE<br />
POTENTIALISATEUR D’EXPRESSION<br />
D’UN GENE REGULATEUR DE LA<br />
SYNTHESE DES PROTEINES<br />
(71) KABUSHIKI KAISHA HAYASHIBARA<br />
SEIBUTSU KAGAKU KENKYUJO<br />
[JP/JP]; 2-3, Shimoishii 1-chome,<br />
Okayama-shi, Okayama 700-0907 (JP).<br />
(for all designated States except / pour tous<br />
les États désignés sauf US)<br />
(72, 75) YANAI, Yoshiaki [JP/JP]; c/o Kabushiki<br />
Kaisha Hayashibara Seibutsu Kagaku<br />
Kenkyujo, 2-3, Shimoishii 1-chome,<br />
Okayama-shi, Okayama 700-0907 (JP).<br />
SANO, Osamu [JP/JP]; c/o Kabushiki Kaisha<br />
Hayashibara Seibutsu Kagaku Kenkyujo, 2-3,<br />
Shimoishii 1-chome, Okayama-shi, Okayama<br />
700-0907 (JP). KURIMOTO, Masashi<br />
[JP/JP]; c/o Kabushiki Kaisha Hayashibara<br />
Seibutsu Kagaku Kenkyujo, 2-3, Shimoishii<br />
1-chome, Okayama-shi, Okayama 700-0907<br />
(JP).<br />
(81) CA KR US.<br />
Published / Publiée :(n)<br />
Declarations / Déclarations :<br />
(v) for the following designations / pour les<br />
désignations suivantes : CA KR; (v) for the<br />
following designation / pour la désignation<br />
suivante : US<br />
(51) 7 A61K 38/39, C07K 1/113, A61P 43/00<br />
(11) WO 02/36154 (13) A2<br />
(21) <strong>PCT</strong>/EP01/12663<br />
(22) 31 Oct/oct 2001 (31.10.2001)<br />
(25) de (26) de<br />
(30) 100 53 870.3 31 Oct/oct 2000 DE<br />
(31.10.2000)<br />
(43) 10 May/mai <strong>2002</strong> (10.05.<strong>2002</strong>)<br />
(54) PROCOLLAGEN (III) PROPEPTIDES<br />
AND RELATED SUBSTANCES FOR<br />
TREATING FIBROTIC DISEASES<br />
PROPEPTIDES DE PROCOLLAGENE<br />
(III) ET SUBSTANCES DERIVEES<br />
POUR LE TRAITEMENT DE MALA-<br />
DIES FIBREUSES<br />
(71, 72) BURCHARDT, Elmar, R. [DE/DE];<br />
Damaschkeweg 69, 42113 Wuppertal (DE).<br />
(74) VOSSIUS & PARTNER; Siebertstrasse 4,<br />
81675 München (DE).<br />
(81) AE AG AL AM AT AU AZ BA BB BG BR<br />
BY BZ CA CH CN CO CR CU CZ DE DK<br />
DM DZ EC EE ES FI GB GD GE GH GM<br />
HR HU ID IL IN IS JP KE KG KP KR KZ<br />
LC LK LR LS LT LU LV MA MD MG MK<br />
MN MW MX MZ NO NZ OM PH PL PT RO<br />
RU SD SE SG SI SK SL TJ TM TR TT TZ<br />
UA UG US UZ VN YU ZA ZW.<br />
(84) AP (GH GM KE LS MW MZ SD SL SZ TZ<br />
UG ZW); EA (AM AZ BY KG KZ MD RU<br />
TJ TM); EP (AT BE CH CY DE DK ES FI<br />
FR GB GR IE IT LU MC NL PT SE TR); OA<br />
(BF BJ CF CG CI CM GA GN GQ GW ML<br />
MR NE SN TD TG).<br />
(51) 7 A61K 38/45, A61P 7/04 // (A61K 38/45,<br />
38:37) (A61K 38/45, 38:11) (A61K 38/45,<br />
38:37, 38:11)<br />
(11) WO 02/36155 (13) A1<br />
(21) <strong>PCT</strong>/US01/47073<br />
(22) 5 Nov/nov 2001 (05.11.2001)<br />
(25) en (26) en<br />
(30) 60/245,751 3 Nov/nov 2000 US<br />
(03.11.2000)<br />
(43) 10 May/mai <strong>2002</strong> (10.05.<strong>2002</strong>)<br />
(54) USE OF BLOOD COAGULATION<br />
FACTOR XIII FOR TREATING<br />
HAEMOPHILIA A<br />
UTILISATION DU FACTEUR XIII DE<br />
COAGULATION SANGUINE DANS LE<br />
TRAITEMENT DE L’HEMOPHILIE A<br />
(71) ZYMOGENETICS, INC. [US/US]; 1201<br />
Eastlake Avenue East, Seattle, Wa Washington<br />
98102 (US).